Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 23% ± 5% | |
| T cell | 6 studies | 29% ± 3% | |
| CD8-positive, alpha-beta T cell | 6 studies | 28% ± 12% | |
| natural killer cell | 6 studies | 39% ± 16% | |
| plasmablast | 5 studies | 32% ± 17% | |
| CD4-positive, alpha-beta T cell | 5 studies | 27% ± 12% | |
| erythroblast | 5 studies | 49% ± 21% | |
| GABAergic neuron | 5 studies | 31% ± 16% | |
| oligodendrocyte | 5 studies | 24% ± 6% | |
| B cell | 4 studies | 23% ± 6% | |
| hematopoietic precursor cell | 4 studies | 31% ± 11% | |
| pro-B cell | 4 studies | 29% ± 10% | |
| epithelial cell | 4 studies | 33% ± 11% | |
| erythrocyte | 4 studies | 46% ± 17% | |
| gamma-delta T cell | 4 studies | 24% ± 13% | |
| glutamatergic neuron | 4 studies | 39% ± 15% | |
| astrocyte | 4 studies | 29% ± 5% | |
| interneuron | 4 studies | 35% ± 19% | |
| retinal cone cell | 3 studies | 19% ± 2% | |
| ciliated cell | 3 studies | 17% ± 1% | |
| effector memory CD4-positive, alpha-beta T cell | 3 studies | 20% ± 2% | |
| regulatory T cell | 3 studies | 27% ± 10% | |
| dendritic cell | 3 studies | 22% ± 6% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 40% ± 22% | |
| basal cell | 3 studies | 23% ± 3% | |
| neuron | 3 studies | 27% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 5% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 24% ± 10% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 100% | 618.11 | 359 / 359 | 100% | 13.83 | 286 / 286 |
| ovary | 100% | 955.18 | 180 / 180 | 100% | 13.98 | 428 / 430 |
| esophagus | 100% | 837.10 | 1445 / 1445 | 99% | 13.38 | 182 / 183 |
| lung | 99% | 702.99 | 575 / 578 | 100% | 13.19 | 1151 / 1155 |
| breast | 100% | 762.54 | 459 / 459 | 99% | 14.38 | 1108 / 1118 |
| intestine | 100% | 841.69 | 966 / 966 | 99% | 14.51 | 520 / 527 |
| brain | 99% | 896.51 | 2619 / 2642 | 99% | 9.70 | 701 / 705 |
| uterus | 100% | 900.15 | 170 / 170 | 98% | 22.63 | 450 / 459 |
| bladder | 100% | 726.19 | 21 / 21 | 98% | 15.08 | 494 / 504 |
| pancreas | 100% | 374.51 | 327 / 328 | 98% | 9.04 | 174 / 178 |
| thymus | 100% | 697.49 | 653 / 653 | 97% | 9.70 | 584 / 605 |
| prostate | 100% | 791.27 | 245 / 245 | 96% | 8.41 | 482 / 502 |
| skin | 100% | 1152.87 | 1809 / 1809 | 96% | 10.80 | 451 / 472 |
| adrenal gland | 100% | 826.35 | 258 / 258 | 90% | 10.44 | 208 / 230 |
| kidney | 100% | 588.48 | 89 / 89 | 87% | 5.61 | 786 / 901 |
| liver | 100% | 366.72 | 225 / 226 | 71% | 5.63 | 290 / 406 |
| adipose | 100% | 685.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 18.23 | 29 / 29 |
| spleen | 100% | 1018.07 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.55 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.66 | 1 / 1 |
| blood vessel | 100% | 676.53 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 496.31 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 444.16 | 830 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 6.34 | 66 / 80 |
| peripheral blood | 80% | 595.80 | 746 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032781 | Biological process | positive regulation of ATP-dependent activity |
| GO_0006334 | Biological process | nucleosome assembly |
| GO_0005615 | Cellular component | extracellular space |
| GO_0101031 | Cellular component | protein folding chaperone complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0051087 | Molecular function | protein-folding chaperone binding |
| GO_0031072 | Molecular function | heat shock protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0042393 | Molecular function | histone binding |
| Gene name | DNAJC9 |
| Protein name | DnaJ homolog subfamily C member 9 (HDJC9) (DnaJ protein SB73) |
| Synonyms | |
| Description | FUNCTION: Acts as a dual histone chaperone and heat shock co-chaperone . As a histone chaperone, forms a co-chaperone complex with MCM2 and histone H3-H4 heterodimers; and may thereby assist MCM2 in histone H3-H4 heterodimer recognition and facilitate the assembly of histones into nucleosomes . May also act as a histone co-chaperone together with TONSL . May recruit histone chaperones ASF1A, NASP and SPT2 to histone H3-H4 heterodimers . Also plays a role as co-chaperone of the HSP70 family of molecular chaperone proteins, such as HSPA1A, HSPA1B and HSPA8 . As a co-chaperone, may play a role in the recruitment of HSP70-type molecular chaperone machinery to histone H3-H4 substrates, thereby maintaining the histone structural integrity . Exhibits activity to assemble histones onto DNA in vitro . . |
| Accessions | Q8WXX5 ENST00000372950.6 |